Entry Point Capital, LLC Bioventus Inc. Transaction History
Entry Point Capital, LLC
- $221 Million
- Q4 2024
A detailed history of Entry Point Capital, LLC transactions in Bioventus Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 26,323 shares of BVS stock, worth $274,022. This represents 0.12% of its overall portfolio holdings.
Number of Shares
26,323
Previous 39,302
33.02%
Holding current value
$274,022
Previous $469,000
41.15%
% of portfolio
0.12%
Previous 0.27%
Shares
3 transactions
Others Institutions Holding BVS
# of Institutions
159Shares Held
46.7MCall Options Held
253KPut Options Held
92.9K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$136 Million31.61% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$72.2 Million28.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.03MShares$41.9 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$25.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$24.7 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $642M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...